Form 4 for CRM Salesforce
Accepted 2024-02-23 00:00:00 ET · period of report 2024-02-22 · accession 0001127602-24-006719 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-23 | 2024-02-22 | CRM | Millham Brian | Pres, COO | M - OptEx | $223.62 | +14.5K | 3,764 | New | +$3.25M |
| D | 2024-02-23 | 2024-02-22 | CRM | Millham Brian | Pres, COO | S - Sale+OE | $292.50 | -14.5K | 0 | -100% | -$4.25M |
| DM | 2024-02-23 | 2024-02-22 | CRM | Millham Brian | Pres, COO | M - OptEx | $0.00 | -14.5K | 3,491 | -81% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-22 | M | A | 8,646 | $240.95 | 14,517 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-22 | M | A | 2,107 | $218.21 | 5,871 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-22 | M | A | 1,746 | $154.14 | 1,746 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-22 | S | D | 14,517 | $292.50 | 0 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-22 | M | A | 2,018 | $215.17 | 3,764 | D | — | — | |
| 6 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-02-22 | M | D | 2,018 | $0.00 | 26,232 | D | $215.17 · 2022-03-22 to 2028-03-22 | 2,018 Common Stock | (F3) Option is exercisable and vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 7 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-02-22 | M | D | 8,646 | $0.00 | 103,752 | D | $240.95 · 2022-02-22 to 2028-02-22 | 8,646 Common Stock | (F5) Option is exercisable and vests over four years at the rate of 25% on February 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 8 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-02-22 | M | D | 2,107 | $0.00 | 52,667 | D | $218.21 · 2023-03-22 to 2029-03-22 | 2,107 Common Stock | (F4) Option is exercisable and vests over four years at the rate of 25% on March 22, 2023, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 9 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-02-22 | M | D | 1,746 | $0.00 | 3,491 | D | $154.14 · 2021-04-22 to 2027-04-22 | 1,746 Common Stock | (F2) Option is exercisable and vests over four years at the rate of 25% on April 22, 2021, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |